Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ultragenyx Pharmaceutical (RARE) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Ultragenyx Pharmaceutical (RARE) over the last 10 years, with Q3 2025 value amounting to 0.51.

  • Ultragenyx Pharmaceutical's Asset Utilization Ratio rose 5252.52% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 5252.52%. This contributed to the annual value of 0.37 for FY2024, which is 3082.02% up from last year.
  • As of Q3 2025, Ultragenyx Pharmaceutical's Asset Utilization Ratio stood at 0.51, which was up 5252.52% from 0.47 recorded in Q2 2025.
  • Over the past 5 years, Ultragenyx Pharmaceutical's Asset Utilization Ratio peaked at 0.51 during Q3 2025, and registered a low of 0.2 during Q1 2021.
  • In the last 5 years, Ultragenyx Pharmaceutical's Asset Utilization Ratio had a median value of 0.3 in 2023 and averaged 0.3.
  • In the last 5 years, Ultragenyx Pharmaceutical's Asset Utilization Ratio surged by 9345.24% in 2021 and then tumbled by 261.32% in 2022.
  • Over the past 5 years, Ultragenyx Pharmaceutical's Asset Utilization Ratio (Quarter) stood at 0.23 in 2021, then fell by 1.73% to 0.23 in 2022, then surged by 38.56% to 0.32 in 2023, then rose by 15.75% to 0.37 in 2024, then soared by 37.14% to 0.51 in 2025.
  • Its Asset Utilization Ratio was 0.51 in Q3 2025, compared to 0.47 in Q2 2025 and 0.42 in Q1 2025.